DK1420788T3 - Nye piperidin-2,6-dion-bisulfatsalte og deres anvendelse til behandling af stressrelaterede emotionelle lidelser - Google Patents
Nye piperidin-2,6-dion-bisulfatsalte og deres anvendelse til behandling af stressrelaterede emotionelle lidelserInfo
- Publication number
- DK1420788T3 DK1420788T3 DK02755226T DK02755226T DK1420788T3 DK 1420788 T3 DK1420788 T3 DK 1420788T3 DK 02755226 T DK02755226 T DK 02755226T DK 02755226 T DK02755226 T DK 02755226T DK 1420788 T3 DK1420788 T3 DK 1420788T3
- Authority
- DK
- Denmark
- Prior art keywords
- dione
- stress
- treatment
- bisulphate
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0120821A GB2379216A (en) | 2001-08-28 | 2001-08-28 | Piperidin-2,6-dione salts useful for the treatment of stress-related affective disorders |
| PCT/GB2002/003869 WO2003020275A1 (en) | 2001-08-28 | 2002-08-22 | Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1420788T3 true DK1420788T3 (da) | 2007-02-26 |
Family
ID=9921084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02755226T DK1420788T3 (da) | 2001-08-28 | 2002-08-22 | Nye piperidin-2,6-dion-bisulfatsalte og deres anvendelse til behandling af stressrelaterede emotionelle lidelser |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7189742B2 (pt) |
| EP (1) | EP1420788B1 (pt) |
| JP (1) | JP2005502677A (pt) |
| KR (1) | KR100906893B1 (pt) |
| CN (1) | CN100506229C (pt) |
| AT (1) | ATE347891T1 (pt) |
| AU (1) | AU2002321522B2 (pt) |
| BR (1) | BR0212175A (pt) |
| CA (1) | CA2459009C (pt) |
| CY (1) | CY1105979T1 (pt) |
| DE (1) | DE60216776T2 (pt) |
| DK (1) | DK1420788T3 (pt) |
| ES (1) | ES2275898T3 (pt) |
| GB (1) | GB2379216A (pt) |
| IL (2) | IL160615A0 (pt) |
| MX (1) | MXPA04001777A (pt) |
| NZ (1) | NZ531345A (pt) |
| PT (1) | PT1420788E (pt) |
| WO (1) | WO2003020275A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219639D0 (en) * | 2002-08-22 | 2002-10-02 | Prestwick Scient Capital Inc | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders |
| US7560861B2 (en) | 2004-05-03 | 2009-07-14 | Lg Electronics Inc. | Organic electro-luminescence display device with an organic electro-luminescence array and fabricating method thereof |
| AU2006224636A1 (en) * | 2005-03-15 | 2006-09-21 | F. Hoffmann-La Roche Ag | Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5HT5A receptor antagonists |
| GB0518763D0 (en) * | 2005-09-14 | 2005-10-19 | Prestwick Pharmaceuticals Inc | Treatment of hypertension |
| KR101401612B1 (ko) * | 2012-04-30 | 2014-06-02 | 재단법인 전남생물산업진흥원 | 석류 추출물을 유효성분으로 포함하는 스트레스성 질환의 치료 및 예방용 조성물 |
| WO2016033094A1 (en) * | 2014-08-25 | 2016-03-03 | Aimmune Therapeutics, Inc. | Egg protein formulations and methods of manufacture thereof |
| EP3377050A4 (en) | 2015-11-17 | 2019-11-20 | The Trustees of Columbia University in the City of New York | PHARMACOLOGICAL PROPHYLACTIC AGENTS AGAINST STRESS INDUCED DISORDERS AND ASSOCIATED SYMPTOMS |
| US11622948B2 (en) | 2017-11-09 | 2023-04-11 | The Trustees Of Columbia University In The City Of New York | Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3693729A (en) * | 1970-02-19 | 1972-09-26 | Global Marine Inc | Air cushion drilling vehicle |
| GB1455687A (en) * | 1972-12-28 | 1976-11-17 | Aspro Nicholas Ltd | Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines |
| EP0216555B1 (en) * | 1985-09-11 | 1992-09-02 | Btg International Limited | Use of dioxopiperidine derivatives in the treatment of anxiety, for the reduction of chronic abnormally high brain levels of serotonin or 5-hydroxy-indoleacetic acid, and in the treatment of bacterial or viral infections |
| DE3779991T2 (de) * | 1986-09-08 | 1993-02-04 | British Tech Group | Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen. |
| US5104990A (en) * | 1990-02-27 | 1992-04-14 | G. D. Searle & Co. | Process for the preparation of 3-aryl-3-aminoalkyl-2,6-dioxohexahydropyridines |
-
2001
- 2001-08-28 GB GB0120821A patent/GB2379216A/en not_active Withdrawn
-
2002
- 2002-08-22 ES ES02755226T patent/ES2275898T3/es not_active Expired - Lifetime
- 2002-08-22 DE DE60216776T patent/DE60216776T2/de not_active Expired - Lifetime
- 2002-08-22 NZ NZ531345A patent/NZ531345A/en not_active IP Right Cessation
- 2002-08-22 BR BR0212175-1A patent/BR0212175A/pt not_active IP Right Cessation
- 2002-08-22 AT AT02755226T patent/ATE347891T1/de active
- 2002-08-22 WO PCT/GB2002/003869 patent/WO2003020275A1/en active IP Right Grant
- 2002-08-22 AU AU2002321522A patent/AU2002321522B2/en not_active Ceased
- 2002-08-22 US US10/486,925 patent/US7189742B2/en not_active Expired - Fee Related
- 2002-08-22 MX MXPA04001777A patent/MXPA04001777A/es active IP Right Grant
- 2002-08-22 CN CNB028169123A patent/CN100506229C/zh not_active Expired - Fee Related
- 2002-08-22 CA CA2459009A patent/CA2459009C/en not_active Expired - Fee Related
- 2002-08-22 JP JP2003524582A patent/JP2005502677A/ja active Pending
- 2002-08-22 DK DK02755226T patent/DK1420788T3/da active
- 2002-08-22 PT PT02755226T patent/PT1420788E/pt unknown
- 2002-08-22 EP EP02755226A patent/EP1420788B1/en not_active Expired - Lifetime
- 2002-08-22 IL IL16061502A patent/IL160615A0/xx active IP Right Grant
- 2002-08-22 KR KR1020047002723A patent/KR100906893B1/ko not_active IP Right Cessation
-
2004
- 2004-02-26 IL IL160615A patent/IL160615A/en not_active IP Right Cessation
-
2007
- 2007-02-01 CY CY20071100144T patent/CY1105979T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1420788E (pt) | 2007-03-30 |
| GB0120821D0 (en) | 2001-10-17 |
| WO2003020275A1 (en) | 2003-03-13 |
| KR100906893B1 (ko) | 2009-07-08 |
| ATE347891T1 (de) | 2007-01-15 |
| JP2005502677A (ja) | 2005-01-27 |
| KR20040031000A (ko) | 2004-04-09 |
| CN1549715A (zh) | 2004-11-24 |
| US7189742B2 (en) | 2007-03-13 |
| BR0212175A (pt) | 2004-07-20 |
| GB2379216A (en) | 2003-03-05 |
| IL160615A0 (en) | 2004-07-25 |
| CY1105979T1 (el) | 2011-04-06 |
| NZ531345A (en) | 2005-07-29 |
| DE60216776D1 (de) | 2007-01-25 |
| EP1420788B1 (en) | 2006-12-13 |
| AU2002321522B2 (en) | 2006-10-12 |
| MXPA04001777A (es) | 2004-11-22 |
| EP1420788A1 (en) | 2004-05-26 |
| IL160615A (en) | 2008-08-07 |
| DE60216776T2 (de) | 2007-10-04 |
| ES2275898T3 (es) | 2007-06-16 |
| CA2459009C (en) | 2010-04-06 |
| US20040249159A1 (en) | 2004-12-09 |
| CN100506229C (zh) | 2009-07-01 |
| CA2459009A1 (en) | 2003-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1395567T3 (da) | 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser | |
| CY1105979T1 (el) | Νεα οξινα θειικα αλατα πιπepιδινο-2,6-διονων και η χρηση τους για την αντιμετωπιση σχετιζομενων με το στρες συναισθηματικων διαταραχων | |
| HK1167646A1 (pt) | ||
| ATE446286T1 (de) | Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems | |
| NO20035496D0 (no) | Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes | |
| DK1265615T3 (da) | Ny kombination af ikkesederende antihistaminika med substanser, der påvirker leukotrien-virkningen, til behandling af rhinitis/conjunctivtis | |
| DK1265900T3 (da) | 1,5-disubstituerede 3,4-dihydro-1H-pyrimido 4,5-dpyrimidin-2-on-forbindelser og deres anvendelse ved behandling af CSBP/P38-kinasemedierede sygdomme | |
| DK1339406T3 (da) | Piperazinderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af lidelser i centralnervesystemet | |
| NO20071574L (no) | Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander. | |
| DK1140915T3 (da) | 4-(aminomethyl)-piperidinbenzamider til behandling af gastrointestinale forstyrrelser | |
| DE602006001590D1 (de) | 7-(2-(4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyrid-1-yl)ethyl)isochinolin-besylatsalz, dessen herstellung und dessen therapeutische verwendung | |
| CY1105541T1 (el) | Παμοϊκα αλατα πιπεριδινο-2,6-διονων και η χρηση τους για την αντιμετωπιση σχετιζομενων με το στρες συναισθηματικων διαταραχων | |
| NO20035116D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| NO20023448L (no) | Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin | |
| DK1267847T3 (da) | 5HT2-antagonist til regulering af IOP og behandling af glaucom | |
| DK1254905T3 (da) | 4-(2-pyridyl)piperiziner med 5HT7 receptoragonistaktivitet | |
| NO20035117D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| DK1257278T3 (da) | Anvendelse af mirtazapin til behandling af sövnforstyrrelser | |
| NO20035118D0 (no) | 4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser | |
| NO941256L (no) | 3-(N-isopropyl-N-n-propylamino)-5-(N-isopropyl)karbamoylkroman | |
| DK1471916T3 (da) | Behandling af rheumatoid arthritis under anvendelse af imatinib | |
| EE200300535A (et) | 4-(fenüül(piperidiin-4-üül)amino)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks | |
| DK0854146T3 (da) | Substitueret 4-(6-fluor-[1H]-indol-3-yl)-1,2,3,6-tetrahydropyridin til behandling af CNS forstyrrelser | |
| DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser | |
| NO20055514L (no) | Piperazinderivater og deres anvendelse ved behandling av neurologiske og psykiatriske sykdommer |